Naringenin: A potential flavonoid phytochemical for cancer therapy M Motallebi, M Bhia, HF Rajani, I Bhia, H Tabarraei, N Mohammadkhani, ... Life sciences 305, 120752, 2022 | 102 | 2022 |
Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies AL Mueller, Z Payandeh, N Mohammadkhani, SMH Mubarak, A Zakeri, ... Cells 10 (11), 3017, 2021 | 87 | 2021 |
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential M Poorebrahim, N Mohammadkhani, R Mahmoudi, M Gholizadeh, ... Cancer gene therapy 28 (6), 581-589, 2021 | 46 | 2021 |
Statins: Complex outcomes but increasingly helpful treatment options for patients N Mohammadkhani, S Gharbi, HF Rajani, A Farzaneh, G Mahjoob, ... European Journal of Pharmacology 863, 172704, 2019 | 34 | 2019 |
Exosome application in tumorigenesis: diagnosis and treatment of melanoma M Karami Fath, A Azargoonjahromi, N Jafari, M Mehdi, F Alavi, M Daraei, ... Medical Oncology 39 (2), 19, 2022 | 13 | 2022 |
The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies Z Payandeh, N Mohammadkhani, M Nabi Afjadi, S Khalili, M Rajabibazl, ... Expert review of anti-infective therapy 19 (7), 899-910, 2021 | 11 | 2021 |
Modulation of tumor vasculature network: key strategies M Taleb, N Mohammadkhani, F Bahreini, M Ovais, G Nie Small Structures 3 (6), 2100164, 2022 | 8 | 2022 |
Update on immune‐based therapy strategies targeting cancer stem cells A Izadpanah, N Mohammadkhani, M Masoudnia, M Ghasemzad, ... Cancer Medicine 12 (18), 18960-18980, 2023 | 7 | 2023 |
Immune checkpoint inhibitors promising role in cancer therapy: Clinical evidence and immune-related adverse events SM Meybodi, B Farasati Far, A Pourmolaei, F Baradarbarjastehbaf, ... Medical Oncology 40 (8), 243, 2023 | 7 | 2023 |
Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies. Cells 10 (11): 3017 AL Mueller, Z Payandeh, N Mohammadkhani, SMH Mubarak, A Zakeri, ... | 5 | 2021 |
Long non-coding RNAs as novel targets for phytochemicals to cease cancer metastasis S Rajabi, HF Rajani, N Mohammadkhani, AA Ramírez-Coronel, M Maleki, ... Molecules 28 (3), 987, 2023 | 4 | 2023 |
Saffron (Crocins) against cancer M Bhia, HF Rajani, N Mohammadkhani, SM Jafari Nutraceuticals and Cancer Signaling: Clinical Aspects and Mode of Action …, 2021 | 4 | 2021 |
CAR‐T cells in brain tumors and autoimmune diseases–from basics to the clinic M Poorebrahim, N Mohammadkhani, M Foad, EF Abazari, ... Front Clin Drug Res 9, 65, 2021 | 1 | 2021 |
Development of Stable CHO-K1 Cell Lines Overexpressing Full-Length Human CD20 Antigen N Mohammadkhani, A Rahimpour, R Hoseinpoor, M Rajabibazl Iranian biomedical journal 27 (5), 269, 2023 | | 2023 |
CART-T Cells in Brain Tumors and Autoimmune Diseases–From Basics to the Clinic. S Sadeghi, Z Amtul, M Poorebrahim, I Quiros Fernandez, A Cid-Arregui, ... D122 AG Gezielte Tumorvakzine, 2021 | | 2021 |
Avances recientes en la comprensión de la patogenia de la artritis reumatoide: nuevas estrategias de tratamiento AL Mueller, Z Payandeh, N Mohammadkhani, SMH Mubarak, A Zakeri, ... | | |